TipRanks
CASI Pharmaceuticals (CH:ENM)
:ENM
Switzerland Market
ENM
CASI Pharmaceuticals
RESEARCH TOOLSreports

CASI Pharmaceuticals (ENM) Income Statement

0 Followers

CASI Pharmaceuticals Income Statement

Last quarter (Q2 2026), CASI Pharmaceuticals's total revenue was $4.91M, an increase of 17.57% from the same quarter last year. In Q2, CASI Pharmaceuticals's net income was $-10.02M. See CASI Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Mar 25Dec 23Mar 23Dec 21
Total Revenue
$ 20.71M$ 28.54M$ 33.88M$ 43.11M$ 30.17M
Gross Profit
$ 10.06M$ 11.15M$ 20.05M$ 27.28M$ 17.61M
Operating Expenses
$ 52.90M$ 50.77M$ 45.13M$ 53.77M$ 59.13M
Depreciation and Amortization
$ 1.26M$ 2.33M$ 3.74M$ 2.42M$ 1.81M
EBITDA
$ -43.77M$ -34.87M$ -21.54M$ -35.79M$ -33.40M
Operating Income
$ -42.85M$ -39.62M$ -25.08M$ -26.49M$ -41.52M
Other Income/Expenses
$ -5.21M$ 1.55M$ -1.21M$ -11.79M$ 5.67M
Pretax Income
$ -48.06M$ -38.07M$ -26.29M$ -38.28M$ -35.84M
Net Income
$ -48.06M$ -39.26M$ -26.94M$ -41.01M$ -36.65M
Per Share Metrics
Basic EPS
$ -2.59$ -2.56$ -2.02$ -3.01$ -2.69
Diluted EPS
$ -2.59$ -2.56$ -2.02$ -3.01$ -2.69
Weighted Average Shares Outstanding
 18.54M 15.34M 13.36M 13.65M 13.61M
Weighted Average Shares Outstanding (Diluted)
 18.54M 15.34M 13.36M 13.65M 13.61M
Currency in USD

CASI Pharmaceuticals Earnings and Revenue History